345 related articles for article (PubMed ID: 16763172)
21. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
Hong SC; Zhao SP; Wu ZH
Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
[TBL] [Abstract][Full Text] [Related]
22. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
Mehta VB; Zhou Y; Radulescu A; Besner GE
Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
[TBL] [Abstract][Full Text] [Related]
23. Novel biological functions of high-density lipoprotein cholesterol.
Mineo C; Shaul PW
Circ Res; 2012 Sep; 111(8):1079-90. PubMed ID: 23023510
[TBL] [Abstract][Full Text] [Related]
24. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
[TBL] [Abstract][Full Text] [Related]
25. HDL stimulation of endothelial nitric oxide synthase: a novel mechanism of HDL action.
Mineo C; Shaul PW
Trends Cardiovasc Med; 2003 Aug; 13(6):226-31. PubMed ID: 12922018
[TBL] [Abstract][Full Text] [Related]
26. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
[TBL] [Abstract][Full Text] [Related]
27. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
28. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
[TBL] [Abstract][Full Text] [Related]
29. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.
Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA
J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927
[TBL] [Abstract][Full Text] [Related]
30. New strategies in managing and preventing atherosclerosis: focus on HDL.
Price MJ; Shah PK
Rev Cardiovasc Med; 2002; 3(3):129-37. PubMed ID: 12439437
[TBL] [Abstract][Full Text] [Related]
31. Regulation of eNOS in caveolae.
Mineo C; Shaul PW
Adv Exp Med Biol; 2012; 729():51-62. PubMed ID: 22411313
[TBL] [Abstract][Full Text] [Related]
32. Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice.
Harder C; Lau P; Meng A; Whitman SC; McPherson R
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):858-64. PubMed ID: 17272756
[TBL] [Abstract][Full Text] [Related]
33. HDL-C: clinical equipoise and vascular endothelial function.
Campbell S; Genest J
Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):343-53. PubMed ID: 23469914
[TBL] [Abstract][Full Text] [Related]
34. Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats.
Mohammadi MS; Thabut D; Cazals-Hatem D; Galbois A; Rudler M; Bonnefont-Rousselot D; Moreau R; Lebrec D; Tazi KA
Liver Int; 2009 May; 29(5):692-700. PubMed ID: 19040541
[TBL] [Abstract][Full Text] [Related]
35. High-density lipoprotein: a potent inhibitor of inflammation.
Murphy AJ; Woollard KJ
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):710-8. PubMed ID: 19930423
[TBL] [Abstract][Full Text] [Related]
36. High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease.
Besler C; Heinrich K; Riwanto M; Lüscher TF; Landmesser U
Curr Pharm Des; 2010 May; 16(13):1480-93. PubMed ID: 20196740
[TBL] [Abstract][Full Text] [Related]
37. Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells.
Maniatis NA; Brovkovych V; Allen SE; John TA; Shajahan AN; Tiruppathi C; Vogel SM; Skidgel RA; Malik AB; Minshall RD
Circ Res; 2006 Oct; 99(8):870-7. PubMed ID: 16973909
[TBL] [Abstract][Full Text] [Related]
38. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
[TBL] [Abstract][Full Text] [Related]
39. High-density lipoproteins, inflammation and oxidative stress.
Tabet F; Rye KA
Clin Sci (Lond); 2009 Jan; 116(2):87-98. PubMed ID: 19076062
[TBL] [Abstract][Full Text] [Related]
40. Activation of intracellular signaling systems by high-density lipoproteins.
Toth PP
J Clin Lipidol; 2010; 4(5):376-81. PubMed ID: 21122681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
